Balance Sheet - Centessa Pharmaceuticals plc (CNTA)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 294.58 | 482.18 | 256.55 | 393.64 | 595.08 | 7.23 | 0.00 |
| Accounts receivable, net | 45.30 | 39.15 | 26.72 | 16.81 | 2.93 | ||
| Inventories | 0.00 | -29.99 | -17.81 | 1.00 | |||
| Other current assets | 73.30 | 8.94 | 19.40 | 17.38 | 16.88 | 3.94 | 0.00 |
| Total current assets | 367.88 | 536.41 | 315.09 | 437.75 | 628.77 | 11.17 | 19.23 |
| Total non-current assets | 319.62 | 40.39 | 45.15 | 6.56 | 0.86 | 0.55 | |
| Total assets | 687.50 | 576.80 | 360.25 | 444.31 | 629.64 | 11.72 | 19.73 |
| Total current liabilities | 42.94 | 58.00 | 39.39 | 38.34 | 24.64 | 8.62 | 1.93 |
| Total non-current liabilities | 117.70 | 117.26 | 84.62 | 69.80 | 113.44 | 25.52 | |
| Total liabilities | 160.63 | 175.25 | 124.00 | 108.14 | 138.08 | 8.62 | 6.07 |
| Total stockholders' equity | 526.86 | 401.55 | 236.24 | 336.17 | 491.55 | 3.10 | 13.66 |
| Common shares outstanding | 136 | 114 | 96 | 93 | 90 | 71 | 106 |
Show Quarterly Balance Sheet
Balance Sheet - Centessa Pharmaceuticals plc (CNTA)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 276.59 | 294.58 | 246.21 | 250.72 | 284.51 | 482.18 | 518.45 | 294.83 | 230.18 | 256.55 | 281.34 | 303.59 | 346.23 | 393.64 | 444.84 | 484.16 | 544.47 | 595.08 | 578.82 | 613.76 | 298.61 | 7.23 | 0.00 | 0.00 | 0.00 |
| Accounts receivable, net | 52.21 | 44.10 | 52.70 | 45.30 | 40.04 | 46.99 | 37.18 | 39.15 | 30.39 | 28.42 | 23.39 | 26.72 | 21.71 | 21.80 | 23.14 | 16.81 | 21.56 | 13.94 | 12.95 | ||||||
| Inventories | 0.00 | 0.00 | 17.86 | 14.53 | 11.58 | -29.99 | 9.15 | 12.40 | 12.47 | -17.81 | 10.22 | 14.18 | 1.39 | ||||||||||||
| Other current assets | 72.09 | 73.30 | 9.25 | 5.54 | 10.51 | 8.94 | 9.87 | 13.68 | 17.12 | 19.40 | 20.72 | 18.40 | 3.13 | 17.38 | 1.29 | 1.14 | 1.12 | 16.88 | 32.83 | 15.98 | 15.02 | 3.94 | |||
| Total current assets | 348.68 | 367.88 | 307.68 | 300.36 | 347.72 | 536.41 | 568.36 | 355.50 | 284.48 | 315.09 | 332.45 | 350.41 | 384.33 | 437.75 | 476.99 | 519.50 | 581.20 | 628.77 | 611.65 | 643.68 | 313.64 | 11.17 | |||
| Total non-current assets | 293.08 | 319.62 | 140.63 | 191.76 | 180.13 | 40.39 | 41.35 | 43.34 | 43.70 | 45.15 | 44.91 | 42.51 | 19.53 | 6.56 | 2.37 | 1.55 | 0.99 | 0.86 | 0.56 | 0.08 | 6.88 | 0.55 | |||
| Total assets | 641.76 | 687.50 | 448.30 | 492.13 | 527.85 | 576.80 | 609.72 | 398.85 | 328.17 | 360.25 | 377.36 | 392.92 | 403.86 | 444.31 | 479.36 | 521.05 | 582.19 | 629.64 | 612.21 | 643.76 | 320.52 | 11.72 | |||
| Total current liabilities | 36.57 | 42.94 | 29.12 | 29.69 | 24.20 | 58.00 | 26.41 | 26.76 | 27.44 | 39.39 | 34.95 | 33.87 | 29.69 | 38.34 | 38.19 | 33.57 | 27.19 | 24.64 | 29.14 | 24.19 | 18.98 | 8.62 | |||
| Total non-current liabilities | 117.84 | 117.70 | 117.60 | 117.51 | 117.40 | 117.26 | 84.17 | 85.13 | 85.57 | 84.62 | 83.02 | 82.45 | 80.91 | 69.80 | 68.24 | 67.44 | 74.84 | 113.44 | 33.93 | 33.93 | 22.91 | ||||
| Total liabilities | 154.42 | 160.63 | 146.73 | 147.21 | 141.60 | 175.25 | 110.58 | 111.88 | 113.01 | 124.00 | 117.97 | 116.32 | 110.60 | 108.14 | 106.43 | 101.01 | 102.04 | 138.08 | 63.07 | 58.12 | 41.89 | 8.62 | |||
| Total stockholders' equity | 487.35 | 526.86 | 301.57 | 344.92 | 386.25 | 401.55 | 499.14 | 286.97 | 215.16 | 236.24 | 259.39 | 276.61 | 293.26 | 336.17 | 372.92 | 420.04 | 480.15 | 491.55 | 549.13 | 585.64 | 278.63 | 3.10 | |||
| Common shares outstanding | 154 | 136 | 134 | 134 | 133 | 132 | 116 | 109 | 100 | 98 | 97 | 95 | 95 | 95 | 94 | 94 | 91 | 90 | 90 | 64 | 87 | 106 | 106 | 106 | 106 |